Summary. After perfusion of mouse livers with A14-~2sI-insulin for designated intervals, an acid-wash technique was employed to separately measure the surface-bound (Xs) and intracellular (X 0 A~4-~25I-insulin, as well as intracellular degradation products (Xdeg) of labelled insulin. From the perfusate concentrations (Cp) of A~4JI-insulin, the apparent intrinsic hepatic clearance of labelled insulin at a high dose (0.2 nmol/1) was shown to be 60% smaller than that at a low dose (0.018 nmol/1), indicating that the cellular uptake of insulin is remarkably nonlinear at the concentration range examined. From the time courses of Q, X~, X~ and Xae~, the hepatic insulin disposition was shown to be largely accounted for by the receptor-mediated endocytosis. The observed data at the low dose were analysed to estimate biochemical parameters, (i. e., total receptor number, endocytotic rate constant and intracellular degradation rate constant) according to "receptor-recycling" and "non-receptor-recycling" models, using a computer-aided optimization procedure. The "receptor-recycling" model could not only adequately explain the Cp, X, X~ and Xde~ at the low dose, but also predict the Cp at the high dose. On the other hand, a "non-receptor-recycling" model, in which recycling of receptors was not assumed, could also explain the observed data at the low dose, but failed to predict the Cp at the high dose, indicating that the receptor recycling process is necessary to explain the hepatic insulin clearance at high insulin concentrations, at which hepatic insulin clearance should be limited by the rate of receptor recycling. However, the applicability of our model might be limited within the physiologic insulin concentrations, because of the negative co-operativity of insulinreceptor interaction and a high-capacity, non-degradative and more rapidly recycling pathway for receptors that may occur at high concentrations of insulin. In conclusion, we have developed a mathematical model of hepatic insulin clearance and distribution under physiological conditions, including receptor binding, receptor-mediated endocytosis and receptor recycling, which has been so far demonstrated using isolated hepatocytes.
There is a growing body of evidence that various polypeptides are taken up by their target ceils via receptor-mediated endocytosis [1, 2] . In particular, the uptake of insulin by isolated hepatocytes involves binding to receptors, endocytosis of the insulin-receptor complex, dissociation of the ligand from the receptor in an acidified endosomal compartment, and transport of the ligand to the lysosomes in which the ligand is degraded [3] . On the other hand, the internalized insulin receptors are largely recycled back to the surface of hepatocytes and reutilized [3, 4] .
The liver plays a major role in regulating the peripheral insulin concentration due to extraction of insulin from the portal blood before entrance into the systemic circulation. Therefore, there have been a number of reports measuring hepatic extraction of insulin in in vivo and in isolated perfused livers, which demonstrate a nonlinear hepatic clearance at physiological insulin concentrations [5] [6] [7] . Moreover, it has been proposed that receptor-mediated endocytosis and its subsequent events such as receptor recycling are the major mechanisms by which receptor down-regulation is mediated [8] [9] [10] . However, there have been no explicit approaches to predict the changes in hepatic clearance and distribution of insulin, as well as the changes in surface receptor number in a physiological situation, possibly due to the lack of an adequate kinetic model.
Therefore, in the present study, we performed mouse liver perfusion experiments to examine hepatic clearance and distribution of A~4-125I-insulin, combined with an acidwash technique [11, 12] to separately measure the surfacebound and internalized amounts of A14=125I-insulin, and intracellular degradation products of A~4-125I-insulin in the liver. In order to analyse the observed data, we developed an organ model of hepatic insulin disposition, including receptor binding, receptor-mediated endocytosis and receptor recycling, namely the "receptor-recycling" model. Using this model, we attempted to predict the nonlinear hepatic elimination of insulin and the down-regulation of surface insulin receptors in the liver. The importance of receptor recycling on the hepatic insulin clearance was also discussed.
Materials and methods
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Acid-wash technique in the perfused liver
At designated times after the addition of A,~-~2sI-insulin into the reservoir, the acid-wash technique was performed as previously described [12] . After 20 fractions of acid-washout solution (designated as acid samples) containing acid-extractable radioactivity were sequentially collected the livers were quickly removed and a 1 g portion of each liver was homogenized in 4 ml of ice-cold 1 tool/1 acetic acid containing 6 tool/1 urea. The remaining portion of the liver was weighed and counted for the total radioactivity in a y-counter (model ARC-300, Aloka Co., Ltd., Tokyo, Japan). The tissue homogenates containing acid-resistant radioactivity were then centrifuged at 3000 rev/min for 15 rain in a centrifuge (model RL-500SR Tomy Seiko Co., Tokyo, Japan) at 4 ~ and the obtained supernatants (designated as tissue samples) were transferred to separate tubes for the assay of A1~-~25I-insulin. The percentage of radioactivity recovered in the tissue samples was more than 90%.
Human insulin ~25I-labelled at tyrosine-A> (At4-12sI-insulin), with a specific activity of 2000 Ci-mmol 1, was purchased from Amersham (Amersham, Buckinghamshire, UK). Crystalline porcine insulin and bovine serum albumin (BSA; Fraction V) were obtained from Sigma Chemical Co. (St. Louis, Mo, USA), and trichloroacetic acid (TCA) from Wako Pure Chemical Industries (Osaka, Japan). Bovine erythrocytes were kindly supplied from the Meat Inspection Center of Kanazawa City (Ishikawa, Japan). All other reagents were commercially available and of analytical grade. The labelled insulin was dissolved in phosphate buffered saline (PBS) containing 0.1% BSA and stored at -20 ~ until study. The labelled insulin used was at least 98% pure as assayed by both TCA-precipitability and HPLC analysis.
Animals
Adult male ddY mice were obtained from Sankyo Laboratory Co. (Toyama, Japan) and allowed free access to standard rodent chow and water. Mice were fasted overnight before use.
Analytical methods
For the TCA-precipitation method, perfusate samples (80 l, tl), acid samples (2.5 ml per fraction) or tissue samples (4 ml) were mixed well with 5% TCA solution in a final concentration, kept standing at 4 ~ for 30 rain, and centrifuged at 3000 g for 15 min. For acid samples, 50 gl of perfusate (containing 3% BSA) was added to the mixture as a precipitation carrier. The supernatants were transferred into separate tubes by aspiration. The radioactivity in the precipitates and supernatants was measured in a 3,-counter.
For the HPLC analysis, each sample was deproteinized by mixing vigorously with an equal volume of ethanol, and centrifuged at 10000 g for 5 min in a microcentrifuge (MR-15A, Tomy Seiko Co.) at 4 ~ The ethanol-treated supernatants were filtered through 0.45-~tm millipore filters (type HV; Nihon Millipore Kogyo, Yonezawa, Japan) with the recovery of more than 80%. The resultant filtrates (100 btl) were loaded onto a reversed-phase HPLC column, bt-Bondapak Cz~ (30 cm x 3.9 mm internal diameter, Waters Associates, Inc., Milford, Mass., USA). The eluents were collected automatically and the radioactivity in each fraction (1.0 ml) was measured in a y-counter. The solvent delivery system, equipments, mobile phase, and elution condition are the same as described previously [12] .
In situ liver perfusion
The mice were anaesthetized with intraperitoneal pentobarbital (50 rag-kg-1), and livers were operated on according to the method of Mortimore and Tietze [13] . The livers were cyclically perfused in situ at 37 ~ in a temperature-controlled cabinet. The perfusate consisted of 10% washed bovine erythrocytes, 3% BSA, and 3.69 retool/1 glucose in Krebs-Ringer bicarbonate (KRB) buffer (pH 7.4). Perfusate was continuously oxygenated with 95% 02/5% CO2 by passsage through silastic tubing in an oxygenation chamber. The inlet temperature was kept at 37 ~ After operation, livers were perfused with erythrocyte-free KRB buffer in a single-pass system for 5 rain, and perfused with 12.0 ml erythrocyte-containing KRB buffer in a closed-circuit system for 10 min. Then, a tracer amount of A~4J2sI-insulin (0.44 gCi or 0.018 nmol/1 in a final concentration), with and without 2 nmol/1 of unlabelled insulin, was added in the reservoir which was constantly stirred. Subsequently, portions (100 p.1) of the perfusate were sampled at designated times, and centrifuged for 1 rain in a microcentrifuge to remove erythroeytes. A~4-~25I-insulin in perfusate samples (without erythrocytes) was assayed by either TCA-precipitation or HPLC analysis as described later. Unless otherwise mentioned, the perfusion flow rate (including erythrocytes) was set at 1.85 ml. min-i and the perfusion pressure at 15-18 mm Hg, using a peristaltic pump (model MR Tokyo Rikakikai Co, Tokyo, Japan). During the 30-rain perfusion the concentrations of glutamic oxaloacetic transaminase (GOT) and glutamic pyruvic transaminase (GPT) were determined with a commercial test kit (STA-Test Wako, Wako) to assess the viability of the perfused livers.
"Receptor-recycling" model
Considering a liver perfusion in a recirculation system, we developed an organ model of hepatic insulin clearance and distribution, in which insulin receptors are transferred between the cell surface and intracellular (vesicular) space. The structure of the model is shown in Figure 1 . The differential equations describing the system are as follows: Fig. 1 . The receptor-recycling model of hepatic insulin clearance and distribution. Solid and broken arrows indicate the movements of insulin and its receptors, respectively. The liver is subdivided into the three compartments, i.e., extracellular fluid, cell surface and intracellular (vesicular) space, which are assumed to be well-mixed. Since the partition of A~4-~2sI-insulin to erythrocytes could be neglected by the method described previously [37] , the erythrocyte compartment is not considered. R~ and R~ defines the numbers of surface and internalized receptors, respectively. Xs, X~ and Xdeg define the amounts of surface-bound insulin, internalized insulin and the intracellular degradation products of insulin, respectively. Cp and C~ define the concentrations in the perfusate and extracellular fluid, respectively. The rate constant k~L defines the release of X~g into the extracellular fluid. The other nomenclature is presented in Table 2 . Receptor synthesis, processing and degradation are not involved in this model, because the half-time of receptor turnover, 10 h [8] , far exceeds the time interval (30 min) of the present liver perfusion. The non-specific binding of insulin to hepatocytes was neglected, because it is only about 8% of the total binding in isolated rat hepatocytes [38] .
Since very little ~4C-sucrose is taken up by perfused rat livers [39] , this model confines itself to receptor-mediated endocytosis over and above fluid-phase endocytosis. The total number of mobile receptors, RT (= R~ + R0, and receptor affinity, Kd (= kof/ko,), are assumed to be constant throughout the experiment, according to the previous reports [9, 10] .
released substantially (i.e., kd~g.X~< < krel'Xdeg), Eq.7 can be approximated to:
Data analysis
I2~
The values of X~, X~ and Xd~g were expressed as intact A~4-I-insulin 125 (pmol per g liver), and Cp also as intact A14-I-insulin (pmol per ml perfusate). The hepatic clearance (CL~) of A~4-~25I-insulin was calculated as follows:
where ke is the exponential slope of the disappearance of A,4-125I -insulin in the perfusate, and LW is the liver weight in grammes. Based on the clearance theory [14] , the CLn is a function of Qp and the apparent intrinsic activity of hepatic elimination, Cgint.ap p [14] . The Cgins,ap p is given by:
Determination of kinetic parameters
Since our preliminary simulation indicated that k~,e, kdeg and R T are important parameters that determine the time courses of Cp, Xs, X~ and Xee~ at a tracer dose, these three parameters were optimized by a procedure as described later. The other parameters (i. e., Ve, Vp, Qp, fp, kon, koff, ksp and kret) were measured experimentally cited or calculated from published references ( Table 2 ). For optimization of kinetic parameters, a nonlinear least-squares regression analysis, NONLIN74 [161, was used throughout this study on a digital computer (FACOM-M360AP) at the Information Processing Center, Kanazawa University. In particular, k~p and k,-et were calculated from published data using the methods described as follows:
Calculation of k~p. The apparent endocytotic rate constant (ke,a.~pp)
can be expressed as:
where v is the fraction of surface receptors occupied by insulin and given by:
The values of ksp and ken d were obtained by a nonlinear least-squares regression analysis according to Eq. 11, based on the concentrationdependent kend.ap p values observed in isolated rat hepatocytes [11] .
Calculation ofk,~t. Using v, Eq. 1 can be written as follows [17] :
Since most of the mobile receptors are considered to be located at the surface of hepatocytes in fasted rats (i.e., v -O), RT can be expressed as follows, under the steady-state basal condition (i.e., dRJdt = 0 in Eq. 13):
where R'~.0 represents the Rs under the steady-state basal condition in fasted rats. On the other hand, when non-fasted rats received an intraportal injection of a large excess of unlabelled insulin (i. e., v -1), Eq. 13 can be transformed to: Numbers in parentheses indicate the number of perfused liver preparations from mice; ~ Not detected by radioimmunoassay (< 100 pmol/1); ~ Expressed as the mean + SEM, as assessed by a linear least-squares regression of the glutamic oxaloacetic transaminase (GOT) and glutamic pyruvic transaminase (GPT) activity (milliunits per milliliter) vs. time curves; d Determined by Eq. 9, using the perfusate volume (Vp) and exponential slope (k~) of the disappearance of Ai4J2sI-insulin from the reservoir perfusate;
Determined by Eq. 10, using the fp ( = 1.0), CL. and Qp values According to the report by Ldpez and Desbuquiois [10] , the R's,0/R~.0 value is 1.1, indicating that the R~ in fasted rats is slightly (10%) higher than that in fed rats. Therefore, one can estimate the kret and kend values by fitting the reported RJR~,G vs time curve (i. e., in vivo down-regulation) to Eq. 19, using a nonlinear least-squares regression analysis. In order to optimize the Rr, k,,a and kd~g, the observed data on Cp (0-30 min), X~, Xi (0-20 rain) and Xdeg (0--5 min) at the tracer dose (0.018 nmol/1) were fitted to the simultaneous differential equations (Eqs. 1-6 and 8) by a nonlinear least-squares regression analysis. Moreover, in order to examine the effect of receptor recycling on hepatic insulin clearance, the observed data were also fitted to the simultaneous differential equations of a "non-receptor-recycling" model, in which kr,t is set at zero.
Since the initial values of k,,~, k~,g and RT are required for the above-mentioned optimization procedure, the following methods were employed for the estimation of respective initial values.
Initial estimation Ofkend. Summation of both hand sides of Eqs. 6 and 8 gives: 
Prediction of the time course of Cp at a high dose (2 nmoI/1)
Using the values of R-r, kend and kd~g estimated above at the low dose, both the "receptor-recycling" and "non-receptor-recycling" models were employed to predict the disappearance of A14J25Linsulin from the perfusate at a high dose (2 nmol/1) to test the feasibility of these models. Two nanomolar was chosen as a high concentration of in- Time (rain) Fig. 4 . The disappearance of A~4525I-insutin from the perfusate (O) and the appearance of its degradation products in the per fusate ( 9 ), after bolus administration of a tracer amount of A~4525I-insulin into the reservoir (0.018 nmol/1 in a final concentration) in the perfused mouse liver. Each point and vertical bar represents the mean _+ SEM from 3-13 rats (for labelled insulin) or 4 rats (for degradation products). When At4-12sI-insulin was perfused in the perfusion apparatus without the liver, no loss of the 125I-radioactivity from the reservoir was observed. Thus, the disappearance of Ai4-I2sI-insulin from the reservoir was not due to adsorption of labelled peptide to the perfusion apparatus, but to hepatic elimination. Moreover, when portions of perfusate were occasionally obtained from the perfused livers to examine in vitro degradation of A~aJesI-insulin at 37 ~ there was essentially no change in insulin concentration for up to 60 rain. Therefore, the release of proteases from the perfused livers was negligible
Statistical analysis
Data were analysed by Student's t-test.
Results
In situ liver perfusion
Livers were perfused via the portal vein at a constant physiological pressure with a perfusate containing 10% erythrocytes as an oxygen carrier, and there was no evidence of oedema during the experiment. The characteristics of the perfused mouse livers are summarized in Table 1 . The perfusion flow rate and perfusion pressure were constant during the experiments. The releasing rates of GOT and GPT are close to that of GOP reported in normal rat livers [19] . Taken together, the viability of the livers was judged to be normal and constant.
Figures 2A-E show typical HPLC profiles of 125I-radioactivity collected from the reservoir perfusate at 0, 10, 15, 20, and 30 min. The total radioactivity eluted from the column was almost 100% of the radioactivity loaded onto the column. A small peak eluting at 34 min probably represents a mixture of 12sI-and monoiodotyrosine, because a standard 3-I-L-tyrosine eluted as early as 3.9 min and very close to the salt peak (3.1 rain) under the present analytical condition. The retention time of intact A~4-125I-insulin was 20 min, and it was clearly seen that A~4-125I-insulin was extensively metabolized by the mouse liver during the perfusion. The identity of a small peak eluting at 16 rain (seen in the profiles of the perfusate samples at 10-20 rain) is not clear from the present study, but it possibly represents intermediate degradation products of labelled insulin, because previous HPLC studies have demonstrated TCA-precipitable, insulin-sized intermediate products derived from enzymatic interactions of insulin with hepatocytes [20] .
The relationship of the intactness of A~4J2sI-insulin in perfusate samples between the TCA-precipitation and HPLC-separation methods (Fig.3) indicates that the TCA-precipitation overestimates the intactness of A14-~25I-insulin, as shown in a previous in vivo study [21] , and further underestimates the hepatic insulin clearance. Moreover, correlation of intactness of A~4-12sI-insulin in the acid samples and tissue samples between the two methods was almost superimposed with the curve shown in Figure 3 (not shown). Although HPLC analysis has a greater resolving power to differentiate between the intact peptide and its metabolites compared with other methods, it is laborious to analyse many samples by HPLC. Therefore, we routinely employed the TCA-precipitation method, and the measured TCA-precipitability (%) was converted to the percentage of intact A14J25I-insulin on HPLC, using the correlation between these two methods. Figure 4 shows the disappearance of A14-12sI-insulin from the perfusate and the appearance of its degradation products in the perfusate, after the addition of a tracer amount of A14J2sI-insulin in the reservoir.
Acid-wash technique in the perfused liver
When aliver was washed with ice-cold 154 mmol/1NaC1 for 5 min and then with ice-cold acidic buffer for 20 min, two sharp peaks of ~25I-radioactivity representing the acid-ex- Time (rain) Fig.6A , B. The clearance of A~4-usI-insulin by cyclically perfused mouse livers at low (0.018 nmol/l; 9 and high (2 nmoI/l; 9 ) doses (in panel A). The perfusate concentrations of A14-msI-insulin at a low dose in Figure 4 are presented again in a logarithmic plot. Each point and bar represents the mean _+ SEM from 3-13 rats (for a low dose) or 4 rats (for a high dose). In panel B, the time-courses of acid-extractable ( 9 ) and acid-resistant ( 9 A14-125I-insulin, as well as that of acid-resistant degradation products (A) of A~4-1zsI-insulin are presented. Each point and vertical bar represents the mean +_ SEM from 4 rats. In panels A and B, solid and dashed lines show the computer-generated simulation curves using "receptor-recycling" (kret ~ 0) and "non-receptor-recycling" (k~t = 0) models of hepatic insulin clearance. The curves indicated by arrows especially provide prediction of the disappearance of A~g-125I-insulin at a high dose (2 nmol/1), using the set of parameters determined at the low dose (0.018 nmol/1) tractable and acid-resistant A14-msI-insulin were sequentially eluted from the liver through the outflow cannula (Fig.5) . We analyzed some acid-extractable samples by HPLC and confirmed that more than 90% of the radioactivity represents intact A14-125I-insulin (result not shown).
Hepatic clearance and distribution of Aa4Jz5I-insulin
The time courses of Cp at low and high doses are shown in Figure 6 A. According to a linear regression analysis, the ke values were determined to be 0.0739+0.0017 and H. Sato et al.: Receptor-recycling model of hepatic insulin clearance 0.0436 + 0.0015 min-1 (mean _+ SD) with the correlation coefficients (r) of -0.998 (p<0.001) and -0.995 (p < 0.001) at low and high doses, respectively. These ke values are significantly different from each other, as assessed by Student's t-test (p < 0.001). In a separate in vitro experiment, protein binding of A14J25I-insulin in the perfusate (KRB buffer containing 3% BSA) was examined using the polyethylene glycol precipitation method [22] , and fp was determined to be 1.0. Thus, the CLH and CLint,app of A14J25I-insulin at these doses were calculated by Eqs. 9 and 10, respectively, and are listed in Table 1 . The CLint,app at the high dose was shown to be 60% smaller than that at the low dose, indicating that the cellular uptake of insulin is remarkably nonlinear at the concentration range examined. Moreover, the time courses of acid-extractable and acid-resistant A14J25I-insulin, as well as that of acid-resistant degradation products of A~4J25I-insulin at the tracer dose are shown in Figure 6 B.
Kinetic analysis
The ksp and kret values were determined to be 0.022 and 0.11 rain -1 by Eq.11 and Eq.19, respectively (Table 2) . Using Eqs.21 and 23, the initial estimates of kena and kdeg were given as 0.655-i-_ 0.046 and 0.693 + 0.024 min-1 (mean + SD) with the r values of 0.998 (p < 0.05) and 0.999 (p < 0.05), respectively. Using Eq. 24, the initial estimate of RT was given as 11.1 pmol per liver. The RT, kend and kdeg were then optimized by fitting the observed data at the low dose (Fig. 6) to Eqs. 1-6 and 8 using a nonlinear leastsquares regression analysis, and are listed in Table 2 .
The "receptor-recycling" model ( Fig.l) could adequately explain the hepatic clearance (Fig. 6 A) and distribution (Fig. 6B ) of A14-125I-insulin at the low dose. The "non-receptor-recycling" model, in which no recycling of receptors (kret = 0) was assumed, could also simulate the observed data at the tracer dose, using another set of optimized parameters (i.e., kend; 0.600---0.036 min -1, kdeg; 0.866 + 0.058 min-X, RT; 9.93 + 0.57 pmol per g liver, mean + SD). On the other hand, a good prediction of the hepatic insulin clearance at the high dose was accomplished by the receptor-recycling model, but not by the non-receptor-recycling model (Fig. 6 A) .
Moreover, as can be seen from Figure 7 , a computeraided prediction using the receptor-recycling model at varying initial concentrations of insulin (Cp) suggests that the elimination rate constant (ke) reduces dramatically at Cp > 1 nmol/1, and that a marked reduction of surface receptors (i.e., "down-regulation") occurs also at Cp > 1 nmol/1.
Discussion
Our kinetic model of hepatic insulin disposition includes several assumptions and approximations as described in the legend to Figure 1 . Unique to this model is the ability to predict the changes in surface receptor number in relation to extracellular insulin as well. By use of this model, moreover, one could also examine quantitatively how the Obtained as the sum of interstitial volume (V~s) and capillary volume (VcB). The Vis was determined to be 0.55 ml using ~4C-inulin in mice (unpublished observation), and the VcB was extrapolated from the reference value in the rat liver [36] to be 0.14 ml in the mouse liver; u Mean + SD, estimated from the observed data on X,, X~, Xa~g and Cp (Fig. 6) according to Eqs. 1~5 and 8, using a nonlinear least-squares regression analysis [16] ; ~ Mean +SD, estimated from the reported data [11] according to Eq. 11 using a nonlinear least-squares regression analysis [16] ; d Mean_+SD, estimated from the reported data [10] according to Eq. 19 using a nonlinear least-squares regression analysis [16] hepatic insulin clearance would be affected by variations in the affinity of insulin-receptor interaction, which may result from mutation of insulin receptor, abnormalities of insulin processing or mutation of insulin itself. However, the applicability of our model might be limited within the physiologic insulin concentrations, because of the negative co-operativity of insulin-receptor interaction [23] and a high-capacity, non-degradative and more rapidly recycling pathway for receptors that occurs at high (supraphysiologic) concentrations of insulin [24] .
Since about 50% of liver cells are not hepatocytes [25] , there is a possibility that the observed clearance and distribution of Ai4-125I-insulin in the perfused livers are not due to specific interactions with hepatocytes. However, we could exclude this possibility, because the initial distribution of 125I-insulin was limited to the hepatocyte plasmalemma after its intraportal injection [26, 27] , and its localization was diminished with simultaneous injection of excess unlabelled insulin [27] .
In this study, an effective separation between the acidextractable and acid-resistant AH-125I-insulin was performed by the acid-wash technique. Moreover, our preliminary experiments show that 125I-radioactivity in both the acid-extractable and acid-resistant samples considerably decreased in the presence of 1 gmol/1 unlabelled insulin in the perfusate, and t25I-radioactivity in the acidresistant samples markedly decreased in the presence of 250 gmol/1 of an endocytosis inhibitor, phenylarsine oxide (results not shown). These lines of evidence suggest that the observed acid-resistant A14-125I-insulin largely represents the intracellular A~4J25I-insulin, and that the acidextractable ~2SI-radioactivity was bound to surface receptors.
As shown in Figure 6 B, the peak of the intracellular A~4-125I-insulin was several minutes later than that of surface-bound At4-t25I-insulin, suggesting that the surfacebound ligand may be regarded as the substrate of endocytosis. Moreover, the increase of degradation products of A14-x2sI-insulha in the reservoir was small for the first 5 min, and rapidly increased thereafter. Since the lag time for Ai4J25I-insulin in the reservoir to reach the inlet of the organ was subtracted from the sampling time, this is not due to an access delay of A~4-~25I-insulin to the liver. Therefore, that the major site of insulin degradation is in an intracellular compartment but not in an extracellular compartment is suggested in this study, as reported by other workers [28, 29] . Taken altogether, the results obtained indicate that the hepatic insulin clearance is largely accounted for by the receptor-mediated endocytosis in the perfused mouse livers, and supports the feasibility of the present model of hepatic insulin clearance and distribution.
As listed in Table 2 , the value of RT was estimated to be 8.66 pmol per g liver, that is 44000 sites per cell, assuming that the number of hepatocytes per liver in mice is the same as that in rats, 1.3 • 108 cells per g liver [30] . This RT value is in good agreement with the Rs for isolated rat hepatocytes in vitro, e. g., 45 000 [31] and 50100 sites per cell [32] , in which almost all mobile receptors may be located on the surface of isolated cells due to the absence of extracellular insulin during preparation. On the other hand, the estimated kend is somewhat greater than that reported for isolated rat hepatocytes, 0.38 min -1 [24] .
A good agreement between the observed and simulated values of Cp, Xs, Xi and Xdeg at the low dose by both the receptor-recycling and non-receptor-recycling models suggests that internalization process, not receptor recycling, is important for the hepatic insulin clearance at low insulin concentrations. On the other hand, the predictions of Cp at the high dose by these models suggest an important role of receptor recycling in the hepatic insulin clearance at high insulin concentrations, at which surface receptors are considered to be largely occupied. It probably, therefore, follows that when the Rs is considerably decreased at high insulin doses, the hepatic insulin clearance should be limited by the rate of receptor recycling. We propose, therefore, that the rate-limiting step of hepatic intrinsic clearance of insulin is the internalization process at low insulin concentrations, but moved to the receptor reycling process at relatively high concentrations. This is consistent with the fact that chloroquine, which blocks receptor recycling via preventing intravesicular acidification [2] , did not alter the disappearance of A14-125I-insulin (tracer dose) in the perfused rat livers [33] . Thus, a dynamic "receptor-recycling" model could be advantageous to a static model of insulin clearance [34] that assumes a constant surface receptor number, because the latter model cannot evaluate the significance of receptor recycling on hepatic insulin clearance. From the computer simulation, it was predicted that the changes in the ke (as well as CLn) and Rs are not so sensitive to the initial concentrations of less than I nmol/1 and more than 10 nmol/1, while very sensitive to those of 1-10 nmol/1. This is in agreement with the report that the hepatic extraction of insulin is reduced with increasing endogenous insulin secretion after pancreatic stimulation with oral glucose [35] , when the portal vein insulin is reported to be 4.5-7.0 nmol/1 [5] . However, further study should be focussed on the validation of the model at a wider concentration range of insulin, and, if necessary, a more detailed modelling of hepatic insulin disposition should be performed to accommodate a full dose response curve as shown in Figure 7 A.
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In conclusion, we have developed a "receptor-recycling" model of hepatic insulin clearance, based on a physiological and biochemical approach. The model could afford to predict not only the nonlinear clearance and distribution of insulin in the perfused liver, but also the change in surface receptor number, in a quantitative manner. The mathematical methods described here should be useful to analyse the receptor-mediated endocytosis of other ligands in an intact organ.
